相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
Celina Wu et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes
Ruben van Doorn et al.
ACTA NEUROPATHOLOGICA (2012)
Star Trk(B) The astrocyte path to neurodegeneration
Emanuela Colombo et al.
CELL CYCLE (2012)
Gender-based blood transcriptomes and interactomes in multiple sclerosis: Involvement of SP1 dependent gene transcription
Ramesh Menon et al.
JOURNAL OF AUTOIMMUNITY (2012)
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration
Emanuela Colombo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis
Roberta Brambilla et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
Ruben Deogracias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IκB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-κB in the central nervous system
Jenni Raasch et al.
BRAIN (2011)
Human Neurotrophin Receptor p75NTR Defines Differentiation-Oriented Skeletal Muscle Precursor Cells: Implications for Muscle Regeneration
Emanuela Colombo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Sphingosine Kinase 1 and Sphingosine 1-Phosphate Receptor 3 Are Functionally Upregulated on Astrocytes under Pro-Inflammatory Conditions
Iris Fischer et al.
PLOS ONE (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The outs and the ins of sphingosine-1-phosphate in immunity
Sarah Spiegel et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune Encephalomyelitis
Zizhen Kang et al.
IMMUNITY (2010)
Blood sphingolipidomics in healthy humans: impact of sample collection methodology
Samar M. Hammad et al.
JOURNAL OF LIPID RESEARCH (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system
Taro Okada et al.
CELLULAR SIGNALLING (2009)
Transgenic Inhibition of Astroglial NF-κB Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation
Roberta Brambilla et al.
JOURNAL OF IMMUNOLOGY (2009)
Transgenic inhibition of astroglial NF-κB leads to increased axonal sparing and sprouting following spinal cord injury
Roberta Brambilla et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Molecular dissection of reactive astrogliosis and glial scar formation
Michael V. Sofroniew
TRENDS IN NEUROSCIENCES (2009)
Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease
Yun-Ping Wu et al.
HUMAN MOLECULAR GENETICS (2008)
Thematic review series: Sphingolipids - Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling
Deborah A. Lebman et al.
JOURNAL OF LIPID RESEARCH (2008)
"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
K. Takabe et al.
PHARMACOLOGICAL REVIEWS (2008)
Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
Kumlesh K. Dev et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
Carolyn A. Foster et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Vittorio Calabrese et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration
San Ching et al.
JOURNAL OF NEUROSCIENCE (2007)
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors
Florian Mullershausen et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Astrocytes are active players in cerebral innate immunity
Cinthia Farina et al.
TRENDS IN IMMUNOLOGY (2007)
Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy
G Melli et al.
BRAIN (2006)
Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation
B Cannella et al.
ANNALS OF NEUROLOGY (2004)
Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes
SD Sorensen et al.
MOLECULAR PHARMACOLOGY (2003)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes
V Trajkovic et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)